Chrysalis Ventures manages one of Mid-America’s largest funds for early-stage and growth investments, primarily in the Healthcare and Technology sectors. Headquartered in Louisville, Kentucky, Chrysalis has approximately $400 million under management and has invested in over 65 companies since 1993.
OCA Ventures is a venture capital firm focused on equity investments in companies with dramatic growth potential, primarily in technology and highly-scalable services businesses. Over the last decade, OCA has invested three funds in over 45 companies. The spinoff OCA EDGE fund invests smaller amounts in seed or very early stage rounds of highly scalable technology businesses.
River Cities Capital Funds invests in market-validated, fast-growing healthcare and information technology companies in the less efficient, lower end of the growth equity market. With over $500 million of capital raised and a consistent track record of entrepreneurial success, River Cities has established itself as a preferred source of growth capital. The firm is actively seeking new investments for its fifth fund.
TriStar Health Partners is an early stage venture firm that focuses on forming and investing in companies in the area broadly defined as healthcare innovation: life sciences, medical technologies, healthcare IT and healthcare services. TriStar’s mission is to identify, create and grow early stage, transformative healthcare companies in the Southeast and beyond.
Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. They provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs.